R Cumming. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » Aminobutyrates/adverse effectsAminobutyrates/therapeutic useChlorobenzenes/adverse effectsChlorobenzenes/therapeutic useClinical Trials as TopicEthnic GroupsHumansMultiple Sclerosis/drug therapyMultiple Sclerosis/epidemiologyMuscle Spasticity/drug therapyParasympatholytics/adverse effectsParasympatholytics/therapeutic useUnited Kingdom
Substances: See more » AminobutyratesChlorobenzenesParasympatholytics
Year: 1972 PMID: 4585728
Source DB: PubMed Journal: Postgrad Med J ISSN: 0032-5473 Impact factor: 2.401